Professional Documents
Culture Documents
FdS5Fd4WEemM4RJ8zQwjOA Medications For AUD Resource Sheet
FdS5Fd4WEemM4RJ8zQwjOA Medications For AUD Resource Sheet
Oral Injectable
Naltrexone Naltrexone Acamprosate Disulfiram Topiramate Gabapentin
Mechanism Antagonist at Antagonist at Unknown; Inhibits breakdown of Unknown, Unknown,
of Action opiate opiate receptors modulates glutamate acetaldehyde by exerts action at action at calcium
receptors inhibiting the enzyme, GABAA and channels indirect
aldehyde glutamate receptors effects on GABA
dehydrogenase concentration
Relative • Current • Current opioid use • Severe kidney • Psychosis or • History of kidney • Potential for
contra- opioid use • Acute hepatitis disease impaired cognition stones misuse and
indications • Acute or liver failure (CrCl < 30mL/min) • Severe coronary • Risk of metabolic diversion
hepatitis or artery disease acidosis • Dose adjusted in
liver failure Acute angle kidney disease
glaucoma
Duration: Medications for addiction treatment should be extended as long as is necessary and in partnership with the patient.
Note: This chart is just for reference. Consult the prescriber medication guide for complete details before prescribing these medications.